|
|
|
|
| LEADER |
00000pam a2200000 a 4500 |
| 001 |
p713620 |
| 005 |
20231013130219.0 |
| 008 |
020521t20022002nyua b 001 0 eng |
| 010 |
|
|
|a 2002072267
|
| 015 |
|
|
|a GBA3-22692
|
| 016 |
7 |
|
|a 101159162
|2 DNLM
|
| 020 |
|
|
|a 0789015846
|
| 020 |
|
|
|a 0789015854
|
| 035 |
|
|
|a (OCoLC)49926328
|
| 040 |
|
|
|a DLC
|c DLC
|d YDX
|d UKM
|d NLM
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 049 |
|
|
|a MPAA
|
| 050 |
0 |
0 |
|a RS100
|b .R95 2002
|
| 082 |
0 |
0 |
|a 362.1/782
|2 21
|
| 100 |
1 |
|
|a Rychlik, Reinhard.
|0 n 81076364
|
| 245 |
1 |
0 |
|a Strategies in pharmacoeconomics and outcomes research /
|c Reinhard Rychlik.
|
| 264 |
|
1 |
|a New York :
|b Pharmaceutical Products Press,
|c [2002]
|
| 264 |
|
4 |
|c ©2002
|
| 300 |
|
|
|a xi, 214 pages :
|b illustrations ;
|c 23 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Drugs
|x Cost effectiveness.
|0 sh 85039719
|
| 650 |
|
0 |
|a Chemotherapy
|x Economic aspects.
|0 sh 85023041
|
| 650 |
|
0 |
|a Outcome assessment (Medical care)
|0 sh 94002382
|
| 650 |
|
7 |
|a Medication.
|2 homoit
|0 homoit0001007
|
| 650 |
|
7 |
|a Therapies.
|2 homoit
|0 homoit0001366
|
| 951 |
|
|
|a 713620
|
| 994 |
|
|
|a E0
|b MPA
|
| 999 |
f |
f |
|i 3aff5ff6-0c14-5991-b7cd-839fd8dfae40
|s a1d8de40-7f81-578c-b40e-445f4e2b03f5
|t 0
|
| 952 |
f |
f |
|p Can circulate
|a Massachusetts College of Pharmacy and Health Sciences
|b Boston Campus
|c MCPHS Boston Library
|d Boston Circulation
|t 0
|e RS100 .R95 2002
|h Library of Congress classification
|i Book
|m 0113401638003
|
